A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

NCT05862272 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

1000

Enrollment

INDUSTRY

Sponsor class

Conditions

Uterine Fibroids
Endometriosis

Interventions

DRUG: Relugolix Combination Tablet

Sponsor

Sumitomo Pharma Switzerland GmbH